VUTURO, Onofrio
 Distribuzione geografica
Continente #
NA - Nord America 572
EU - Europa 270
AS - Asia 85
Continente sconosciuto - Info sul continente non disponibili 1
Totale 928
Nazione #
US - Stati Uniti d'America 572
UA - Ucraina 67
FI - Finlandia 66
CN - Cina 62
IT - Italia 48
IE - Irlanda 23
GB - Regno Unito 16
SE - Svezia 15
DE - Germania 12
SG - Singapore 8
BE - Belgio 7
RU - Federazione Russa 6
KR - Corea 5
FR - Francia 4
IR - Iran 3
TR - Turchia 3
IN - India 2
RO - Romania 2
AT - Austria 1
CZ - Repubblica Ceca 1
EU - Europa 1
HK - Hong Kong 1
NL - Olanda 1
PL - Polonia 1
UZ - Uzbekistan 1
Totale 928
Città #
Chandler 74
Fairfield 61
Ashburn 51
Wilmington 38
Ann Arbor 37
Jacksonville 36
Houston 35
Des Moines 28
Dublin 23
Seattle 23
Woodbridge 22
New York 19
Cambridge 18
Medford 15
Nanjing 13
Princeton 11
Boardman 10
Tulsa 9
Brussels 7
Dearborn 7
Nanchang 6
Palermo 6
Shenyang 6
Altamura 5
Lawrence 5
Seongnam 5
Hebei 4
Ningbo 4
San Diego 4
Singapore 4
Beijing 3
Changsha 3
Haikou 3
Hangzhou 3
Izmir 3
Tehran 3
Tianjin 3
Chicago 2
Duncan 2
Guangzhou 2
Jinan 2
Kiev 2
Kunming 2
Lanzhou 2
Milan 2
Castagnole delle Lanze 1
Central District 1
Den Haag 1
Hefei 1
Helsinki 1
Islington 1
Jiaxing 1
Kilburn 1
Kumar 1
Ludwigshafen am Rhein 1
Olomouc 1
Orange 1
Redmond 1
Saint Petersburg 1
Salerno 1
San Mateo 1
Taiyuan 1
Taizhou 1
Tappahannock 1
Venice 1
Verona 1
Zhengzhou 1
Totale 645
Nome #
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. 151
Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C. 123
Leucocyte interferon-alpha for patients with chronic hepatitis C intolerant to other alpha-interferons 119
Retreatment of interferon plus ribavirin unresponsive patients with chronic hepatitis C with peginterferon alfa 2a plus mycofenolatemofetile or peginterferon alfa 2 a plus ribavirin 88
Affidabilità del Bright liver echopattern nella diagnosi di steatosi in pazienti con ipertransaminasemia criptogenetica 85
Himpact of liver steatosis on the antiviral response in the hepatitis C virus –associated chronic hepatitis. 84
Safety and efficacy of peginterferon alpha 2a plus mycofenolatemofetile and peginterferon alpha 2a plus Ribavirin in unresponsive patients with chronic hepatitis C 71
safety and efficacy of peginterferon (PEG-IFN) alpha 2a plus mycofenolatemoftile and peginterfron alpha 2a plus ribavirin in unresponsive patients with chronic C hepatitis 66
Viral clearance in HCV viraemic patients with normal aminotransferase after combination therapy: a controlled, open-labelled study 55
Safety and efficacy of Peginterferon (PEG-IFN) alpha 2 a(40 Kda) plus mycofenolatemofetile (MMF) and Peginterferon alpha 2 a plus Ribavirin (RBV) in unresponsive patients with chronic C hepatitis (CHC). 54
Randomised trial of two different daily doses of interferon-α versus classical therapy in treatment-naïve patients with chronic hepatitis C 53
Totale 949
Categoria #
all - tutte 3.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.078


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020220 30 3 14 14 24 28 29 10 24 8 23 13
2020/2021116 1 14 6 13 11 6 10 6 15 6 11 17
2021/2022105 3 28 1 9 3 2 5 4 10 13 7 20
2022/2023172 14 28 1 21 24 31 22 13 9 1 6 2
2023/202491 5 9 3 25 4 20 2 2 0 0 8 13
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 949